Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-OIC-16008797Phase 4Recruiting
Phase 4, open-label, single-arm trial of liqihuoxue diwan in coronary arteriosclerosis and angina pectoris, sponsored by Shanghai Changzheng Hospital. Primary endpoint: Safety. Started Jul 2015; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-OIC-16008797.